NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Take Solutions Ltd Sees 2% Upper Circuit on AI-Driven Health Companion Launch

Market Update On March 24, Take Solutions Ltd reached a 2% upper circuit, trading at ₹38.10 on the BSE. The company has launched Take.Health, a unified, AI-driven health companion platform aimed at transforming everyday lifestyle and medical data into actionable, personalized health insights.

Key Highlights

  • Take.Health is strategically positioned at the intersection of digital health, artificial intelligence, and consumer wellness.
  • The platform aims to provide scalable solutions for retail consumers and enterprise clients, facilitating early diagnosis, preventive healthcare, and recurring revenue streams.
  • The launch represents a key milestone in Take Solutions Ltd's strategic progression toward growth driven by innovation in the healthcare technology sector.

Market Opportunity India's healthcare industry is undergoing significant transformation, with the total healthcare market projected to reach USD 370 billion. The preventive healthcare sector alone offers a potential of USD 197 billion. Take.Health is poised to address gaps in accessibility, affordability, and awareness, aligning with the Government of India's vision of leveraging artificial intelligence for inclusive development and social advancement.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Stock Performance While Take Solutions Ltd has shown mixed performance across different timeframes, the longer-term trend remains strong. The stock has delivered a sharp 259.43% gain over the past six months, indicating underlying strength and investor interest.

Investor Takeaway

Investors should consider the growth potential of companies at the intersection of digital health and AI.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.